NEW VULVODYNIA TREAMENT RESEARCH
THE CENTER FOR VULVOVAGINAL DISORDERS HAS TWO NEW VULVODYNIA RESEARCH STUDIES. One is for topical ketotifen for inflammatory vestibulodynia and the other is incobotulinumtoxin (Xeomin) for overactive pelvic floor dysfunction. Go to vulvodynia.com/research or email research.cvvd@gmail.com. These studies are being conducted in New York City, Washington DC, Tampa. (please don't ask about other locations, there aren't any).